[Present status of the treatment of chronic hepatitis C in Japan compared from Western countries].
Izumi
Namiki
N
Division of Gastroenterology and Hepatology, Musashino Red-Cross Hospital.
Asahina
Yasuhiro
Y
D000998:Antiviral Agents / Q000627:therapeutic use*; D005060:Europe; D005838:Genotype; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007372:Interferons; D007564:Japan; D011994:Recombinant Proteins; D014481:United States
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D007372:Interferons